A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma
Clinical trial NCT07124936 · RECRUITING
Trial details
- NCT number
- NCT07124936
- Sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-30
- Primary completion
- 2027-10-26
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.